Literature DB >> 24393764

Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.

Qishan Zheng1, Tianran Lin1, Hanyin Wu1, Liangqia Guo2, Peirong Ye1, Yanli Hao1, Qingquan Guo1, Jinzhi Jiang1, Fengfu Fu3, Guonan Chen1.   

Abstract

A novel pH-sensitive controlled release system is proposed by using mussel-inspired polydopamine (PDA) coated mesoporous silica nanoparticles (MSNs) as nanocarriers. MSNs with a large pore diameter are synthesized by using 1,3,5-trimethylbenzene as a pore-expanding agent and are modified with a PDA coating by virtue of oxidative self-polymerization of dopamine in neutral pH. PDA coated MSNs are characterized by FTIR, TEM, N₂ adsorption and XPS techniques. The PDA coating can work as pH-sensitive gatekeepers to control the release of drug molecules from MSNs in response to the pH-stimulus. Doxorubicin (DOX, an anticancer drug) can be released in the acid media and blocked in the neutral media.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Controlled release; Drug delivery; Mesoporous silica nanoparticles; Polydopamine

Mesh:

Substances:

Year:  2014        PMID: 24393764     DOI: 10.1016/j.ijpharm.2013.12.045

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  23 in total

1.  Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.

Authors:  Berrin Küçüktürkmen; Jessica M Rosenholm
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Enhanced cell uptake of fluorescent drug-loaded nanoparticles via an implantable photothermal fibrous patch for more effective cancer cell killing.

Authors:  Yangyang Li; Yike Fu; Zhaohui Ren; Xiang Li; Chuanbin Mao; Gaorong Han
Journal:  J Mater Chem B       Date:  2017-09-07       Impact factor: 6.331

3.  Recyclable nanoscale zero-valent iron-based magnetic polydopamine coated nanomaterials for the adsorption and removal of phenanthrene and anthracene.

Authors:  Jing Li; Qingxiang Zhou; Yongli Liu; Man Lei
Journal:  Sci Technol Adv Mater       Date:  2017-01-06       Impact factor: 8.090

4.  Functional nanovalves on protein-coated nanoparticles for in vitro and in vivo controlled drug delivery.

Authors:  Angela A Hwang; Jie Lu; Fuyuhiko Tamanoi; Jeffrey I Zink
Journal:  Small       Date:  2014-09-05       Impact factor: 13.281

5.  Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers.

Authors:  Joonyoung Park; Tarsis F Brust; Hong Jae Lee; Sang Cheon Lee; Val J Watts; Yoon Yeo
Journal:  ACS Nano       Date:  2014-03-19       Impact factor: 15.881

Review 6.  pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.

Authors:  Mahdi Karimi; Masoud Eslami; Parham Sahandi-Zangabad; Fereshteh Mirab; Negar Farajisafiloo; Zahra Shafaei; Deepanjan Ghosh; Mahnaz Bozorgomid; Fariba Dashkhaneh; Michael R Hamblin
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-14

7.  Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.

Authors:  Yi Wei; Li Gao; Lu Wang; Lin Shi; Erdong Wei; Baotong Zhou; Li Zhou; Bo Ge
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy.

Authors:  Wei Xiong; Lixia Peng; Hongbo Chen; Qin Li
Journal:  Int J Nanomedicine       Date:  2015-04-16

9.  Facile synthesis by a covalent binding reaction for pH-responsive drug release of carboxylated chitosan coated hollow mesoporous silica nanoparticles.

Authors:  Qiang Liu; Jiao Wang; Linnan Yang; Xiaofei Xia; Mei Wang; Shengguang Chen; Rongrong Zhu; Qingxiu Wang; Xianzheng Wu; Shilong Wang
Journal:  IET Nanobiotechnol       Date:  2018-06       Impact factor: 1.847

10.  EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer.

Authors:  Yang Li; Yanhong Duo; Shiyun Bao; Lisheng He; Kai Ling; Jinfeng Luo; Yue Zhang; Hao Huang; Han Zhang; Xiaofang Yu
Journal:  Int J Nanomedicine       Date:  2017-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.